
Fresenius Medical Care AG
FMCQF
Updated: 22/09/2026, 12:03:24
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.
No summaries found.
- Share price
- $44.12
- Market cap
- $11.85B
- Exchange
- OTC
- Currency
- USD
- CEO
- Helen Giza
- Employees
- 111,024
- IPO date
- 07/02/2012
- Beta
- 0.726
- Last dividend
- $0.00
- Day range
- $43.01 – $44.12
- 52-week range
- $42.00 – $56.24
- 1-day performance
- 0.00%
- 1-year performance
- 5.05%
- Current drawdown (1Y)
- -21.55%
- CIK
- 0001333141
- CUSIP
- 32076V103
- ISIN
- DE0005785802
- Created
- 07/12/2025, 04:02:08
- Last update
- 22/09/2026, 12:03:24
Track Fresenius Medical Care AG with an AI analyst
See which prediction-market events move FMCQF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.